Krk Medical Research

Dallas, Texas 75230

0 studies enrolling now · 29 studies all time

What they study most

Analgesia, Chronic Idiopathic Constipation, Chronic Low Back Pain, Chronic Noncancer Pain, Chronic Nonmalignant and Nonneuropathic Pain, Chronic Pain, Depressive Disorder, Major, Hypertension, Low Back Pain, Major Depressive Disorder, Neuropathic Pain, Opioid-induced Bowel Dysfunction

Studies at this site

• A Study of Tanezumab in Adults With Chronic Low Back Pain — Completed
• SPD489 Adult Major Depressive Disorder (MDD) Open-label Safety and Tolerability Rollover Extension Study — Stopped early
• Efficacy and Safety Study of SPD489 in Combination With an Antidepressant in the Treatment of Adults With Major Depressive Disorder — Completed
• A Study to Evaluate the Efficacy and Safety of LCI699 Compared to Placebo in Participants With Resistant Hypertension — Completed
• Long Term Safety Study of Tanezumab in Chronic Low Back Pain — Stopped early
• Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder — Completed
• Study of COV795 in Subjects With Osteoarthritis or Chronic Low Back Pain — Completed
• Long-term Safety of Once-daily Hydrocodone Bitartrate (HYD) Tablets For Moderate to Severe Chronic Nonmalignant and Nonneuropathic Pain. Includes a 24-week Extension Period. — Completed
• Efficacy and Safety of Hydrocodone Bitartrate (HYD) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed
• Opioid-induced Bowel Dysfunction (OBD) Pivotal Assessment of Lubiprostone (OPAL) — Completed
• The Plecanatide Chronic Idiopathic Constipation (CIC) Study — Completed
• A Study to Evaluate the Effect of Lorcaserin Hydrochloride on Smoking Cessation — Completed
• Long-term Open-Label Safety Study to Evaluate EN3409 — Completed
• OnabotulinumtoxinA as Treatment for Major Depressive Disorder in Adult Females — Completed
• Study to Evaluate the Long-Term Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) in Patients Who Require Opioid Treatment for an Extended Period of Time — Completed
• Study to Evaluate the Efficacy and Safety of Hydrocodone Bitartrate Extended-Release Tablets (CEP-33237) for Relief of Moderate to Severe Pain in Patients With Osteoarthritis or Low Back Pain Who Require Opioid Treatment for an Extended Period of Time — Completed
• A Research Study of an Investigational Drug ALO-02 (Oxycodone Hydrochloride and Naltrexone Hydrochloride) in Patients With Moderate to Severe Chronic Low Back Pain — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Naive Subjects — Completed
• Efficacy Study to Evaluate Buprenorphine HCl Buccal Film in Opioid-Experienced Subjects — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes and Inadequately Controlled Hypertension on an Angiotensin-Converting Enzyme Inhibitor or Angiotensin Receptor Blocker — Completed
• A Study of BMS-512148 (Dapagliflozin) in Patients With Type 2 Diabetes With Inadequately Controlled Hypertension on an ACEI or ARB and an Additional Antihypertensive Medication — Completed
• Safety Study of Oxycodone Hydrochloride and Naltrexone Hydrochloride Extended-Release Capsules in Subjects With Moderate to Severe Chronic Noncancer Pain — Completed
• Safety and Tolerability Extension Trial for Patients With Chronic Idiopathic Constipation — Completed
• 26 Week Efficacy and Safety Trial for Patients With Chronic Idiopathic Constipation — Stopped early
• Efficacy and Safety of EN3324 (Axomadol) in Subjects With Chronic Low Back Pain — Completed
• Evaluation of Clinical Equivalence Between Two Lubiprostone Products in the Treatment of Chronic Idiopathic Constipation — Completed
• Study Evaluating Desvenlafaxine Succinate Sustained-Release (DVS SR) in Adult Outpatients With Major Depressive Disorder (MDD) — Completed
• Switching to Iloperidone From Other Antipsychotics in Schizophrenia — Completed
• Buprenorphine Transdermal System (BTDS) in Subjects With Moderate to Severe Chronic Low Back Pain — Completed